Wist u dat uw browser verouderd is?

Om de best mogelijke gebruikerservaring van onze website te krijgen raden wij u aan om uw browser te upgraden naar een nieuwere versie of een andere browser. Klik op de upgrade button om naar de download pagina te gaan.

Upgrade hier uw browser
Ga verder op eigen risico
Back

DISODIUM PAMIDRONATE PENTAHYDRATE

CAS: 109552-15-0
Business unit: Lab Ofichem
Laboratorium Ofichem BV
CEP / DMF-EU

Information

Pamidronate Disodium Pentahydrate (CAS Nr.: 57248-88-1) is a potent inhibitor of osteoclastic bone resorption (Tumour-induced hypercalcaemia, Osteolytic lesions in patients with bone metastases associated with breast cancer, Multiple myeloma stage III). It binds strongly to hydroxyapatite crystals and inhibits the formation and dissolution of these crystals in vitro. Inhibition of osteoclastic bone resorption in vivo may be at least partly due to binding of the medicinal product to the bone mineral.

Pamidronate suppresses the accession of osteoclast precursors onto the bone and the so induced transformation to mature absorbing osteoclasts. However, the local and direct antiresorptive effect of bone-bound biphosphonate appears to be the predominant mode of action in vitro and in vivo.

Need more information?

Please contact us